Chief Medical and Research Officer (CMO) / Mitglied der Geschäftsleitung (m/w/d)

## Responsibilities - Lead and develop the medical and scientific strategy of the GBG in close collaboration with the CEO, from study idea to clinical implementation. - Initiate and design innovative study concepts integrating the latest insights from data analytics and translational research. - Serve as a contact person for internal and external customers, researchers, and study groups regarding medical questions for current or new studies. - Monitor and evaluate ongoing clinical studies, ensuring the highest quality standards and promoting scientific excellence. - Collaborate with medical departments, project management, and monitoring to ensure study excellence in all phases of the value chain. - Work with the executive board to develop strategies that combine scientific impact, economic stability, and operational efficiency. ## Requirements - Medical license and at least 10 years of clinical experience, ideally in oncology or related fields. - Several years of leadership experience in a scientifically-medical environment (at least 3 years). - Close proximity to operational processes and economic understanding is a must - being hands-on is a given. - Proven experience in developing medical standards, guidelines, and quality processes. - Strategic, analytical, and entrepreneurial thinking - with an eye for innovation and practical feasibility. - Excellent communication and leadership skills in an international environment (German and English fluent). ## Nice to Have - Experience in oncology or related fields. - Strong background in data analytics and translational research. - Experience in international collaboration and project management. ## Benefits - Work-life balance through flexible working hours and the possibility of mobile working (2 days per week). - Numerous opportunities for further development. - Attractive benefits such as the employee support program, JobRad, and free parking, subsidy for the Deutschland-Ticket, and the possibility of company pension. - Opportunity to shape the future of clinical oncology.